NK1 antagonists (Lilly)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNK1 antagonists (Lilly)
Drug Alias Namesubstance P antagonists (Eli Lilly)lanepitant analogs (Lilly)LY-382968
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsPainMigraine DisordersAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsPainMigraine DisordersAsthma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A